Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Modeling TCIRG1 Neutropenia By Utilizing Patient Derived Induced Pluripotent Stem Cells

Vahagn Makaryan, Merideth Kelley, Audrey Anna Bolyard, David C. Dale

Blood (2023) 142 (Supplement 1): 933.

https://doi.org/10.1182/blood-2023-173400

Published: 2023

Journal Articles

Novel TCIRG1 Mutations Causing Congenital Neutropenia

Vahagn Makaryan, Merideth L. Kelley, Audrey Anna Bolyard, Hsiu-Ju Yen, David C. Dale

Blood (2022) 140 (Supplement 1): 8334–8335.

https://doi.org/10.1182/blood-2022-159214

Published: 2022

Journal Articles

The Morphologic Spectrum of Myelokathexis in WHIM Syndrome and Germline CXCR4 Variants: New Insights into Cellular Changes in the Bone Marrow and Peripheral Blood

Blood (2022) 140 (Supplement 1): 5487–5489.

https://doi.org/10.1182/blood-2022-155692

Published: 2022

Journal Articles

Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study

Julia T. Warren, Kelly J. Walkovich, Audrey Anna Bolyard, Kathryn E. Dickerson, Jolan E. Walter, Diego Cadavid, Eloisa Chapa, Kelly Chen, Richard MacLeod, Katie Peters, Richard Polisson, David C. Dale

Blood (2022) 140 (Supplement 1): 1408–1410.

https://doi.org/10.1182/blood-2022-156216

Published: 2022

Journal Articles

Heterozygous variants of CLPB are a cause of severe congenital neutropenia

Julia T. Warren, Ryan R. Cupo, Peeradol Wattanasirakul, David H. Spencer, Adam E. Locke, Vahagn Makaryan, Audrey Anna Bolyard, Merideth L. Kelley, Natalie L. Kingston, James Shorter, Christine Bellanné-Chantelot, Jean Donadieu, David C. Dale, Daniel C. Link

Blood (2022) 139 (5): 779–791.

https://doi.org/10.1182/blood.2021010762

Published: 2022

Includes: Supplemental data

Journal Articles

Mavorixafor, an Oral CXCR4 Antagonist, for Treatment of Patients with WHIM Syndrome: Results from the Long-Term Extension of the Open-Label Phase 2 Study

David C. Dale, Frank Caleb Firkin, Audrey Anna Bolyard, Weihua Tang, Honghua Jiang, Richard MacLeod, Diego Cadavid, Yanping Hu

Blood (2021) 138 (Supplement 1): 1121.

https://doi.org/10.1182/blood-2021-145759

Published: 2021

Journal Articles

Spectrum of Pathogenic Genetic Variants in a Large Cohort of North American Congenital and Cyclic Neutropenia Patients: A Report from the Severe Chronic Neutropenia International Registry

Julia T Warren, Audrey Anna Bolyard, Merideth L. Kelley, Vahagn Makaryan, David C. Dale, Daniel C. Link

Blood (2021) 138 (Supplement 1): 2059.

https://doi.org/10.1182/blood-2021-153783

Published: 2021

Journal Articles

Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome

David C. Dale, Frank Firkin, Audrey Anna Bolyard, Merideth Kelley, Vahagn Makaryan, Kenneth J. Gorelick, Tarek Ebrahim, Varun Garg, Weihua Tang, Honghua Jiang, Renato Skerlj, Sarah Beaussant Cohen

Blood (2020) 136 (26): 2994–3003.

https://doi.org/10.1182/blood.2020007197

Published: 2020

Includes: Supplemental data

Journal Articles

Heterozygous Mutations of Clpb As a Newly Identified and Frequent Cause of Severe Congenital Neutropenia

Julia T Warren, MD PhD, Peeradol Wattanasirakul, David H Spencer, MD, Adam Locke, PhD, Vahagn Makaryan, MD, Audrey Anna Bolyard, RN, BS, Karl Welte, Julia Skokowa, MD PhD, David C. Dale, MD, Daniel C. Link, MD

Blood (2019) 134 (Supplement_1): 433.

https://doi.org/10.1182/blood-2019-129635

Published: 2019

Journal Articles

Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Therapies

David C. Dale, MD, James A. Shannon, IV, Audrey Anna Bolyard, RN, BS, Jim Connelly, MD, Daniel C. Link, MD, Mary Ann Bonilla, MD, Peter E. Newburger, MD

Blood (2019) 134 (Supplement_1): 3589.

https://doi.org/10.1182/blood-2019-126181

Published: 2019

Journal Articles

Family Studies of Whim Syndrome

David C. Dale, MD, Emily Dick, BA, Merideth L. Kelley, MSc, Vahagn Makaryan, MD, Jim Connelly, MD, Audrey Anna Bolyard, RN, BS

Blood (2019) 134 (Supplement_1): 215.

https://doi.org/10.1182/blood-2019-126234

Published: 2019

Journal Articles

Extended Genetic Testing in Severe Congenital Neutropenia May Identify Mutations That Inform Therapy

Daniel C. Link, MD, Vahagn Makaryan, MD, David H Spencer, MDPhD, Jun Xia, PhD, Audrey Anna Bolyard, RN, BS, David C Dale, MD

Blood (2018) 132 (Supplement 1): 2401.

https://doi.org/10.1182/blood-2018-99-116712

Published: 2018

Journal Articles

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

David C Dale, MD, Frank Caleb Firkin, MD, Audrey Anna Bolyard, RN, BS, Merideth L. Kelley, MSc, Emily Dick, BA, Sonja Hartmann, PhD, Karen Brown, PhD, Tarek M Ebrahim, MD, Kenneth J Gorelick, MD, Sudha Parasuraman, MD

Blood (2018) 132 (Supplement 1): 1102.

https://doi.org/10.1182/blood-2018-99-119840

Published: 2018

Journal Articles

Myelodysplasia, Leukemia, Lymphoid Malignancies, and Other Cancers in Patients with Severe Chronic Neutropenia

David C Dale, MD, Audrey Anna Bolyard, RN, BS, Blanche P. Alter, MD MPH, Mary Ann Bonilla, MD, James Connelly, MD, Daniel C. Link, MD, Peter E. Newburger, MD, Philip S. Rosenberg, PhD, Akiko Shimamura, MD PhD, Kelly J. Walkovich, MD

Blood (2018) 132 (Supplement 1): 16.

https://doi.org/10.1182/blood-2018-99-112694

Published: 2018

Journal Articles

X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome

David Dale, MD, Audrey Anna Bolyard, RN, BS, Emily Dick, BA, Merideth L. Kelley, MS, Vahagn Makaryan, MD, Ramsey Johnson, MSM, Lu Gan, MD PhD, Sudha Parasuraman, MD

Blood (2017) 130 (Supplement 1): 995.

https://doi.org/10.1182/blood.V130.Suppl_1.995.995

Published: 2017

Journal Articles

Long-Term Outcomes for G-CSF Treatment of Patients with Glycogen-Storage Disease Type Ib

David Dale, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, David A. Weinstein, MD MMSc, Cornelia Zeidler, Karl Welte

Blood (2017) 130 (Supplement 1): 996.

https://doi.org/10.1182/blood.V130.Suppl_1.996.996

Published: 2017

Journal Articles

Cyclic Neutropenia, Congenital and Idiopathic Neutropenia

David Dale, MD, Audrey Anna Bolyard, RN, BS, Jamie Leung, Emily Tran, Tracy M. Marrero, Peter E. Newburger, MD

Blood (2017) 130 (Supplement 1): 2275.

https://doi.org/10.1182/blood.V130.Suppl_1.2275.2275

Published: 2017

Journal Articles

Peg-Filgrastim for the Treatment of Severe Chronic Neutropenia

Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Laurence A. Boxer, MD, Peter E. Newburger, MD, Mary Ann Bonilla, MD, David C. Dale, MD

Blood (2016) 128 (22): 1332.

https://doi.org/10.1182/blood.V128.22.1332.1332

Published: 2016

Journal Articles

Termination and Frameshift Mutations in ELANE Are Associated with Adverse Outcomes in Patients with Severe Chronic Neutropenia

David C. Dale, MD, Vahagn Makaryan, MD, Merideth L. Kelley, MS, Audrey Anna Bolyard, RN, BS, Laurence A. Boxer, MD, Peter E. Newburger, MD, Mary Ann Bonilla, MD, Maksim Klimiankou, PhD, Julia Skokowa, MD PhD, Cornelia Zeidler, MD MPH, Karl Welte, MD

Blood (2016) 128 (22): 1326.

https://doi.org/10.1182/blood.V128.22.1326.1326

Published: 2016

Journal Articles

TCIRG1 Mutations As a Cause for Chronic Neutropenia

Vahagn Makaryan, MD, Breanna Fletcher, BSc, Merideth L. Kelley, MS, Audrey Anna Bolyard, RN, BS, Daniel C. Link, MD, Eric J. Duncavage, MD, David Augustus Qualls, MD, David C. Dale, MD

Blood (2016) 128 (22): 2511.

https://doi.org/10.1182/blood.V128.22.2511.2511

Published: 2016

NARROW

Modeling TCIRG1 Neutropenia By Utilizing Patient Derived Induced Pluripotent Stem Cells

Novel TCIRG1 Mutations Causing Congenital Neutropenia

The Morphologic Spectrum of Myelokathexis in WHIM Syndrome and Germline CXCR4 Variants: New Insights into Cellular Changes in the Bone Marrow and Peripheral Blood

Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study

Heterozygous variants of CLPB are a cause of severe congenital neutropenia

Mavorixafor, an Oral CXCR4 Antagonist, for Treatment of Patients with WHIM Syndrome: Results from the Long-Term Extension of the Open-Label Phase 2 Study

Spectrum of Pathogenic Genetic Variants in a Large Cohort of North American Congenital and Cyclic Neutropenia Patients: A Report from the Severe Chronic Neutropenia International Registry

Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome

Heterozygous Mutations of Clpb As a Newly Identified and Frequent Cause of Severe Congenital Neutropenia

Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Therapies

Family Studies of Whim Syndrome

Extended Genetic Testing in Severe Congenital Neutropenia May Identify Mutations That Inform Therapy

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

Myelodysplasia, Leukemia, Lymphoid Malignancies, and Other Cancers in Patients with Severe Chronic Neutropenia

X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome

Long-Term Outcomes for G-CSF Treatment of Patients with Glycogen-Storage Disease Type Ib

Cyclic Neutropenia, Congenital and Idiopathic Neutropenia

Peg-Filgrastim for the Treatment of Severe Chronic Neutropenia

Termination and Frameshift Mutations in ELANE Are Associated with Adverse Outcomes in Patients with Severe Chronic Neutropenia

TCIRG1 Mutations As a Cause for Chronic Neutropenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only